IO Biotech
IOBT
IOBT
26 hedge funds and large institutions have $25.3M invested in IO Biotech in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.34% less ownership
Funds ownership: 28.94% → 27.6% (-1.3%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$33.7K | |
| 2 | +$31.5K | |
| 3 | +$18.2K | |
| 4 |
Renaissance Technologies
New York
|
+$17.9K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$14.4K |
Top Sellers
| 1 | -$513K | |
| 2 | -$496K | |
| 3 | -$189K | |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$73.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$50.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SS
26
SBI Securities
Tokyo,
Japan
| $183 |
|
|||
27
Vontobel Holding
Zurich,
Switzerland
| – |
|